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Abstract 
The Zika virus presents a serious risk for global health. Crystal structures of different constructs 
of the Zika virus NS2B-NS3 protease (NS2B-NS3pro) have been determined with the aim to 
provide a basis for rational drug discovery. In these structures, the C-terminal b-hairpin of 
NS2B, NS2Bc, was observed to be either disordered (open conformation) or bound to NS3pro 
complementing the substrate binding site (closed conformation). Enzymatically active constructs 
of flaviviral NS2B-NS3 proteases commonly used for inhibitor testing contain a covalent peptide 
linker between NS2B and NS3pro. Using a linked construct of Zika virus NS2B-NS3pro, we 
studied the location of NS2Bc relative to NS3pro in solution by pseudocontact shifts generated 
by a paramagnetic lanthanide tag attached to NS3pro. Both closed and open conformations were 
observed with different inhibitors. As the NS2B co-factor is involved in substrate binding of 
flaviviral NS2B-NS3 proteases, the destabilization of the closed conformation in the linked 
construct makes it an attractive tool to search for inhibitors that interfere with the formation of 
the enzymatically active, closed conformation.  
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Highlights 
- A linked construct of the Zika virus NS2B-NS3 protease can assume open and closed 
conformations in solution 
- Nuclear magnetic resonance (NMR) experiments with a paramagnetic tag confirm the 
closed conformation in solution 
- A peptide linker between NS2B and NS3pro favours population of the open conformation 
- The linked construct appears ideal to screen for inhibitors that prevent the enzymatically 
active fold of NS2B on NS3pro 
 
 
 
 
Abbreviations 
bZiPro, Zika virus NS2B-NS3 protease expressed in two individual parts; eZiPro, Zika virus 
NS2B-NS3 protease expressed with an enzymatic cleavage site between NS2B and NS3pro; 
gZiPro, Zika virus NS2B-NS3 protease expressed with a Gly4SerGly4 peptide linking NS2B with 
NS3pro; HSQC, heteronuclear single-quantum coherence; NMR, nuclear magnetic resonance; 
NS2B, part B of non-structural protein 2; NS3pro, protease domain of non-structural protein 3; 
PCS, pseudocontact shift; TROSY, transverse relaxation optimized spectroscopy  
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Introduction 
The Zika virus recently emerged as a major threat to global health. It is a flavivirus that depends 
on the activity of a viral NS2B-NS3 protease, which thus is an attractive drug target. Owing to its 
high sequence and structure similarity with other flaviviral NS2B-NS3 proteases, such as the 
West Nile virus (WNV) (Chappell et al., 2008) and dengue virus (Nitsche et al., 2014) proteases, 
an inhibitor of the Zika virus protease could even display broad-spectrum activity against a wide 
range of flaviviruses (Boldescu et al., 2017). As full-length NS2B contains membrane-bound 
segments, an important advance was made when a soluble NS2B-NS3 construct was obtained for 
the dengue virus protease by covalently linking NS2B to the NS3 protease (NS3pro) via a 
covalent Gly4-Ser-Gly4 linker (Leung et al.; 2001). The same approach led to soluble NS2B-
NS3pro constructs of the WNV and Zika virus proteases (Nall et al.; 2004, Lei et al., 2016). 
These constructs are enzymatically active and widely used for activity assays (Nitsche et al., 
2014; 2017). There is no general agreement, however, whether the linked NS2B-NS3pro 
constructs are also the most suitable constructs for drug discovery. 
 NS2B is essential for full enzymatic activity, but crystal structures have found NS2B in 
very different conformations, open and closed, depending on the presence of inhibitors binding 
to the active site (Erbel et al., 2006; Noble et al., 2012; Lei et al., 2016; Chen et al., 2016a; 
Aleshin et al., 2007; Robin et al., 2009; Chandramouli et al., 2010; Hammamy et al., 2013). 
While the N-terminal segment of NS2B always forms an integral part of the b-barrel formed by 
NS3pro, the C-terminal part of NS2B, NS2Bc, forms a b-hairpin that tends to line the substrate 
binding site only in the presence of inhibitors (closed conformation), being dissociated from 
NS3pro in crystal structures without inhibitor (open conformation) (Erbel et al., 2006; Aleshin et 
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al. 2007; Chen et al., 2016a; Lee et al., 2017). In the case of the Zika virus protease, the b-hairpin 
of NS2Bc comprises residues 75*–87* (with the stars identifying residues of NS2B).  
In solution, NMR data of the NS2B-NS3pro constructs from dengue virus, WNV and 
Zika virus showed NS2Bc in the closed conformation in the presence of inhibitors (Su et al., 
2009; de la Cruz et al., 2011; Chen et al., 2014; Chen at al., 2016b; Zhang et al., 2016) and the 
closed conformation was also found in a WNV construct containing the Gly4-Ser-Gly4 linker 
without an inhibitor (Su et al., 2009). Solution NMR spectroscopy further indicated the closed 
conformation in constructs without covalent linkage between NS2B and NS3pro (Kim et al., 
2013; de la Cruz et al., 2014). In the case of the Zika enzyme, however, solution NMR 
experiments revealed a more complex situation. A construct produced without covalent linkage 
between NS2B and NS3pro (named bZiPro) displayed the closed conformation in solution and 
the closed conformation was also captured in the single crystal (Zhang et al., 2016). For a related 
construct with an autocleavage site between NS2B and NS3pro (named eZiPro), however, the 
situation appears to be different in solution than in the single crystal: while the crystal structure 
showed the closed conformation, 15N-relaxation data of NS2Bc indicated high mobility in 
solution, characteristic of the open conformation (Phoo et al. 2016). Although the substrate 
binding site in this construct was occupied by the C-terminal tetrapeptide of NS2B (residues 127-
130), this was apparently not sufficient to maintain the closed conformation in solution. 
Both eZiPro and bZiPro show two sets of cross-peaks for NS2B (Phoo et al., 2016; 
Zhang et al., 2016) which was attributed to the release of NS2B from the NS2B-NS3pro complex 
(Zhang et al., 2016). Greater stability of the protease would be expected for the classical 
construct containing the Gly4-Ser-Gly4 linker. This construct (referred to as gZiPro) has not been 
studied by NMR spectroscopy in the same detail as the unlinked constructs eZiPro and bZiPro. It 
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showed no change of the NMR spectrum with the classical protease inhibitor BPTI, suggesting 
that the covalent linkage prevents binding of the inhibitor (Phoo et al., 2016). 
The question of open or closed conformation of the flaviviral NS2B-NS3 proteases is 
important for the inhibitor design. As crystalline environments can give different answers from 
the situation in solution, it is important to address the question by experiments under near-
physiological conditions, i.e. in solution. To date, structural information on the Zika virus NS2B-
NS3 protease in solution is limited to secondary structure. In this work, we investigated a 
chemically stable Zika virus construct containing the Gly4-Ser-Gly4 linker (gZiPro) by solution 
NMR spectroscopy with and without inhibitors, and determined the location of NS2Bc with 
respect to NS3pro by the use of pseudocontact shifts (PCS) induced by a paramagnetic 
lanthanide tag attached to NS3pro. The results show that gZiPro is a construct that can assume 
both the open and closed conformation in solution, making it an attractive tool for the discovery 
of antiviral drugs that can target either of these conformational states.  
 
Experimental sections 
Materials 
Construct design 
The gene of the gZiPro construct of the ZIKV NS2B-NS3 protease used in the present work was 
synthesized with codon optimization for expression in E. coli (Integrated DNA Technologies), 
based on the amino acid sequence of the South American isolate Z1106033 (GenBank: 
KU312312.1; Enfissi et al., 2016). The construct included the 48 hydrophilic core residues of 
NS2B (residues 48*–95*, where a star identifies NS2B residues) followed by a Gly4SerGly4 
linker, the 170 N-terminal residues of NS3 and a C-terminal His6-tag. The three mutations 
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R95*A, K15N and R29G were introduced to eliminate potential auto-cleavage sites and increase 
protein stability. To allow site-specific ligation of a lanthanide tag to a single, engineered 
cysteine residue, the two native cysteine residues 80 and 143 were mutated to serine. Apart from 
the K15N and the cysteine-to-serine mutations, our construct is closely related to that used for 
the crystal structure 5LC0 (Lei et al., 2016). The gene was cloned between the NdeI and EcoRI 
sites of the T7 vector pETMCSI (Neylon et al., 2000). In addition, the mutant T27C was 
prepared for attaching a lanthanide tag to residue 27. Figure S1 compares the amino acid 
sequences of our construct and previously used gZiPro constructs.  
  
Protein sample preparation 
Uniformly isotope-labelled protein was produced in E. coli BL21(DE3) using a high-cell density 
protocol (Sivashanmugam et al., 2009). Following induction with 1 mM IPTG at an OD600 value 
of about 0.5–0.8, the cells were incubated overnight at 25 °C. Cells were grown in M9 medium 
(6 g/l Na2HPO4, 3 g/l KH2PO4, 0.5 g/l NaCl) supplied with 1 g/l 15NH4Cl) for uniform 15N-
labelling and in 13C/15N-labelled Spectra 9 medium (Cambridge Isotope Laboratories, 
Tewksbury, USA) for double-labelling. The cells were pelleted by centrifuging at 5,000 g for 10 
minutes and lysed by passing twice through a French Press (SLM Aminco, USA) at 830 bars. 
The cell lysate was centrifuged for 1 h at 34,000 g and supernatant was loaded on to a 5 ml Co-
NTA column (GE Healthcare, USA) pre-equilibrated with buffer A (50 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 5% glycerol). The protein was eluted with buffer B (50 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 300 mM imidazole, 5% glycerol) and fractions were analyzed by 12% SDS-
PAGE. Finally, the buffer was exchanged for NMR buffer (20 mM MES, pH 6.5, 150 mM NaCl) 
and 10% D2O was added for NMR measurements.  
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Selectively isotope-labelled protein samples and samples with site-directed mutations for 
resonance assignments were prepared by cell-free protein synthesis  (Ozawa et al., 2004; 
Apponyi et al., 2008) and purified using a 1 ml His GraviTrapTM TALON column (GE 
Healthcare, USA). Cell-free synthesis enabled efficient production of selectively isotope-labelled 
samples (Table S1), including samples where each of the twenty amino acids except Glu, Gln, 
Cys and Pro was selectively labelled with 15N. Cell-free synthesis from PCR-amplified DNA 
(Wu et al., 2007) was also used to obtain site-specific resonance assignments of all eight 
isoleucine residues by individual mutation to valine in eight 15N-isoleucine-labelled samples. 
Similarly, the assignments of valine residues was probed by mutating 20 of 24 valine residues to 
isoleucine in 20 15N-valine-labelled samples. 
The 15N-labelled T27C mutant of Zika NS2B-NS3pro was tagged with lanthanide ions by 
incubation at 25 °C overnight in the presence of three-fold excess C2 tag (Graham et al. 2011; de 
la Cruz et al. 2011) loaded with either paramagnetic Tm3+, Tb3+ or diamagnetic Y3+. Following 
the tagging reaction, the samples were washed with NMR buffer using a centrifugal filter unit 
(Amicon Ultra, molecular weight cut-off 10 kDa; Millipore, Billerica, USA) to remove unbound 
tag. 
 
Inhibitors 
Figure 1 shows the inhibitors used. Inhibitors 1 (corresponding to cn-716) and 2 (corresponding 
to cn-729) were synthesized as described previously (Nitsche et al., 2017). Inhibitor 3 (Lim et al., 
2016) was purchased from Sigma-Aldrich. Protein samples with inhibitors were prepared by 
adding a 1.5-fold of excess of inhibitor 1 and 2 and a four-fold of excess of inhibitor 3. 
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NMR spectroscopy 
NMR spectra were recorded at 25 °C, using 600 MHz and 800 MHz Bruker Avance NMR 
spectrometers equipped with cryoprobes. 3D HNCA and 3D NOESY-15N-HSQC experiments 
were performed with protein concentrations of 0.5–0.8 mM in 5 mm NMR tubes. 2D NMR 
spectra were recorded with 0.1–0.2 mM samples in 3 mm NMR tubes.  
 
Backbone resonance assignments 
For backbone resonance assignments, the 3D HNCA and NOESY-15N-HSQC spectra were 
supplemented by [15N,1H]-HSQC spectra of selectively isotope-labelled samples and samples 
with site-directed mutations. The assignments of NS2Bc residues were supported by recording 
2D BEST-TROSY-HNCO spectra (Solyom et al., 2013).  
 
Dc-tensor fits 
Pseudocontact shifts (PCS), DdPCS, were measured as the difference in amide proton chemical 
shifts observed in NMR spectra recorded with and without paramagnetic metal ion (in ppm). The 
PCSs were used to fit magnetic susceptibility anisotropy (Dc) tensors to the crystal structure 
coordinates using the equation 
 
DdPCS = 1/(12pr3)[Dcax(3cos2q – 1) + 1.5Dcrh sin2q cos2f]        (1) 
 
where r is the distance of the nuclear spin from the metal ion, Dcax and Dcrh are the axial and 
rhombic components of the Dc tensor, and q and f are the polar angles describing the position of 
the nuclear spin with respect to the principal axes of the Dc tensor. The fits were performed 
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using the program Numbat (Schmitz et al., 2008). The quality of the fits were determined by the 
quality factor Q, which was calculated as the root mean square deviation between experimental 
and back-calculated PCSs divided by the root mean square of the the experimental PCSs. 
 
Chemical shift changes 
Chemical shift changes, Dd, were calculated using the equation 
Dd = Sqrt[(DdH)2 + 0.2(DdN)2]              (2) 
where DdH and DdN are, respectively, the changes measured in the 1H and 15N dimensions of 
[15N,1H]-HSQC spectra.  
 
Results 
 
NMR resonance assignments 
The protein was produced in good yields of about 74 mg per litre medium in vivo and about 2 mg 
per mL reaction mixture in cell-free synthesis, but the NMR resonance assignments of the free 
protein were made difficult by a tendency for precipitation, spectral overlap and variable peak 
intensities for different amino acid residues. To assign the backbone amide resonances, we 
supplemented 3D NMR data with 2D [15N,1H]-correlation spectra of selectively isotope-labelled 
protein prepared by cell-free synthesis. [15N,1H]-HSQC spectra were recorded of 16 different 
samples, in which only a single residue type was labelled with 15N. In addition, site-specific 
resonance assignments of isoleucine residues were obtained by isoleucine-to-valine mutations in 
15N-isoleucine-labelled samples. Similarly, 20 out of 24 valine residues were individually 
mutated to isoleucine to assign their amide cross-peaks. Finally, 2D HN(CO) spectra were 
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recorded of eight samples selectively labelled with 15N and 13C (Table S1) to identify the 
[15N,1H]-HSQC cross-peaks of individual residues following a 13C-labelled residue (Kainosho 
and Tsuji, 1982). The final assignment comprised the resonances of 174 out of 216 non-proline 
backbone amides (Figure S2). The cross-peak assignments were confirmed and supported by 
comparison with the assignments published for the slightly different construct eZiPro (Phoo et 
al., 2016). 
In the course of titration with inhibitor 1, NMR signals of NS2Bc disappeared while new 
resonances appeared, indicating that the exchange between inhibitor-bound and free protein is 
slow on the NMR time scale. This was expected, as inhibitor 1 binds with low nanomolar 
affinity, assisted by reversible covalent bond formation of its boronate group with the active-site 
serine (residue 135; Lei et al., 2016). In contrast to previous results obtained with eZiPro and 
bZiPro (Phoo et al., 2016; Zhang et al., 2016), NS2B did not display a set of cross-peaks 
corresponding to free NS2B in the presence of inhibitor 1. Figure 2 shows that, while many 
cross-peaks changed only little following addition of inhibitor 1, others displayed large changes 
in chemical shifts, making it necessary to obtain new resonance assignments. 2D HN(CO) 
spectra of the selectively 15N- and 13C-labelled samples used for resonance assignments of the 
free protein (Table S1) were used to assign the new cross-peaks of NS2Bc appearing after 
addition of inhibitor 1. The chemical shifts of these peaks proved to be close to the better 
dispersed set of cross-peaks reported previously for eZiPro (Phoo et al., 2016).  
 
NS2Bc-NS3pro association in the presence of inhibitor 1 
To assess the location of NS2Bc with respect to NS3pro, we attached the C2 lanthanide tag at 
position 27 in the T27C mutant. Loaded with either Tm3+ or Tb3+, this tag tends to shift the 
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cross-peaks in opposite directions relative to the diamagnetic reference obtained with C2-Y3+, 
facilitating the assignment of the paramagnetic NMR spectra (Nitsche and Otting, 2017). PCSs 
with the C2-Tm3+ tag were observed for over thirty cross-peaks (Table S2, Figure 3), which 
allowed determination of the magnetic susceptibility anisotropy (Dc) tensor using equation 1 
(Table S3). The tensor predicts PCSs of about -0.1 ppm at the site of NS2Bc, if NS2Bc were in 
the closed conformation as in the crystal structures (Figure 4). The experimentally observed 
PCSs of residues 55*–86* in NS2B indeed correlated closely with the predicted PCSs (Figure 5), 
indicating that, in the presence of inhibitor 1, the closed conformation observed in the crystal 
structure 5LC0 is also the prevalent conformation in solution. The closed conformation was also 
supported by similar R2(15N) relaxation rates observed for residues in NS2Bc and NS3pro (data 
not shown). Judging by the quality factor of the Dc-tensor fits, the closed conformation of the 
structure 5LC0 explains the PCSs measured with inhibitor 1 better than the open conformation 
of the structure 5T1V (Table S3).  
 
NS2Bc-NS3pro association in the absence of inhibitors 
To probe the conformation of gZiPro in the inhibitor-free state, we again used the PCSs 
generated by C2-Ln3+ tags attached to position 27 in the T27C mutant (Figure S3). Good Dc-
tensor fits were obtained (Figure S4 and Table S3), but while the amide cross-peaks of residues 
71*, 81*, 82* and 85* of NS2B could be observed in the presence of the diamagnetic C2-Y3+ 
tag, they disappeared in the presence of a paramagnetic C2 tag. The effect can be explained by 
excessive line broadening due to dislocation of NS2Bc from its usual site on NS3pro. This 
dislocation could bring NS2Bc into proximity of the paramagnetic tags where it would be 
exposed to paramagnetic relaxation enhancements. In addition, the signals could be broadened 
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by chemical exchange between environments with different PCSs, if the exchange occurs in the 
intermediate time regime. For the observable PCSs, the open conformation of the crystal 
structure 5T1V fitted the PCSs as well as the closed conformation of the crystal structure 5LC0. 
Dissociation of NS2Bc from NS3pro was supported by R2(15N) relaxation rates, which 
were on average 14 s-1 and about four times smaller than for NS3pro (data not shown). Much 
slower relaxation rates in NS2Bc versus NS3pro have similarly been reported for the eZiPro 
construct (Phoo et al., 2016). In addition, the chemical shifts of all assigned amide protons of 
NS2Bc were in the range 7.6 – 8.6 ppm, which is characteristic of chemical shifts in flexibly 
disordered proteins. The chemical shifts were also close to those reported by Zhang et al. (2016) 
for free NS2B peptide. Therefore, the gZiPro construct used in this work assumes an open 
conformation in solution, if no high-affinity inhibitor is present. 
 
Complexes with inhibitors 2 and 3 
Titration with the inhibitor 2, which differs from inhibitor 1 by an additional t-butyl group and an 
alternative basic P2 side chain (Figure 1), led to the disappearance of the cross-peaks of NS2Bc 
and of many of the NS3pro resonances, suggesting excessive broadening by chemical exchange 
in the intermediate time regime (Figure S5). This result indicates that the structure of the 
complex is destabilized by the steric clash between the t-butyl group and the loop comprising 
residues 154–161 in NS3pro, which is predicted by the crystal structure 5LC0. Previously 
reported IC50 values of inhibitor 2 versus inhibitor 1 indicated weaker binding of inhibitor 2 (2.1 
versus 0.25 nM; Nitsche et al., 2017). While the 1H-NMR signal of the t-butyl group of inhibitor 
2 could readily be observed in the complex with the dengue virus protease (Chen et al. 2016b), it 
was too broad to be resolved in the complex with the Zika virus protease. 
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 Titration with the inhibitor 3 also produced chemical shift changes and line-broadening 
effects (Figure S6). The inhibitor binds in slow exchange. Signals of His51 and Tyr130 in the 
substrate binding site disappeared, and chemical shift changes were observed not only near the 
substrate binding site but also on the far side of the protease (Figure 6A). A wide distribution of 
chemical shift changes was also observed with inhibitor 1, which is known to bind at the active 
site (Figure 6B). Therefore, the data suggest that inhibitor 3, which is active against a range of 
different serine proteases, binds at the active site and the chemical shift changes observed 
elsewhere in the protease reflect allosteric conformational changes. There is no evidence, 
however, that inhibitor 3 induces the closed conformation, as the chemical shifts of residues in 
NS2Bc remained unaffected (Figure S7). 
 
Discussion 
Six different crystal structures of the Zika virus protease have been published and all but two of 
them show the closed conformation, irrespective of the presence or absence of ligands in the 
substrate binding site (Lei et al., 2016; Phoo et al., 2016; Zhang et al., 2016), with no electron 
density observed for NS2Bc in the open conformation (Chen et al., 2016a; Lee et al., 2017). A 
different situation prevails in the case of the related dengue and West Nile virus proteases, for 
which crystal structures in the absence of inhibitors invariably show open conformations, where 
NS2Bc is dissociated from NS3pro (Erbel et al., 2006; Aleshin et al., 2007; Chandramouli et al., 
2010). In the case of the Zika virus protease, the state of NS2Bc in solution has been addressed 
by relaxation experiments performed by NMR spectroscopy, indicating that NS2Bc is associated 
with NS3pro in the construct bZiPro, which has no covalent linkage between NS2B and NS3 
(Zhang et al., 2016). Similarly, in the absence of a linker peptide connecting NS2B and NS3, the 
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closed state has earlier been reported for the dengue virus protease (Kim et al., 2013; de la Cruz 
et al., 2014). Unexpectedly, however, much slower relaxation rates for NS2Bc than NS3pro were 
reported for the autoproteolytically cleaved construct eZiPro, indicating dissociation of NS2Bc 
from NS3pro (Phoo et al., 2016). The authors did not report which of the two sets of cross-peaks 
observed for NS2B were used for relaxation measurements.  
The present work used pseudocontact shifts in order to assess the actual location of 
NS2Bc in a linked gZiPro construct of the Zika virus protease in solution. While PCSs were 
predicted for NS2Bc in the closed conformation and, in fact, observed in the presence of 
inhibitor 1, NS2Bc resonances disappeared in the presence of paramagnetic tags, indicating 
chemical exchange broadening. This can be explained, if NS2Bc exchanges between locations of 
different PCSs in various open conformations. Increased motions are also supported by the 
relaxation and chemical shift data. Notably, however, not all inhibitors induce the closed 
conformation, as shown by the results obtained with inhibitor 3.  
The open conformation is most likely promoted by the artificial linker between NS2B 
and NS3pro. In the wild-type enzyme, no such linkage exists due to an autoproteolytic cleavage 
site. Formally, the linker in gZiPro is represented by only nine residues (Gly4SerGly4), which 
should not be able to span the distance between the last residue of NS2B and the first residue of 
NS3 observed in the crystal structures (about 45 Å, see Figure 4). Notably, however, none of the 
crystal structures report electron density for the N-terminal 14 residues of NS3 and flexible 
disorder of the 17 N-terminal residues was also indicated by greatly reduced R2(15N) and 
increased R1(15N) relaxation rates in the unlinked construct eZiPro (Phoo et al., 2016). These 
residues must thus be included in the flexible link between NS2B and NS3. In fully extended 
conformation, 31 residues could span over 100 Å.  
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As NS2Bc binds only weakly to NS3pro, the open conformation appears as a possible 
target for an inhibitor that, by preventing formation of the closed conformation, greatly 
diminishes the activity of the protease. By biasing the equilibrium between open and closed 
conformation towards the open state, the gZiPro construct could be uniquely suited to probe 
whether an inhibitor induces the closed conformation or binds to the open conformation. For 
quantitative measurements of dissociation constants, gZiPro also has the distinctive advantage of 
not releasing NS2B into the solution, in contrast to the constructs eZiPro and bZiPro. The 
relevance of gZiPro as a research tool has very recently been demonstrated by the identification 
of bromocriptine as an inhibitor of the Zika virus protease with similar activity both in 
biochemical and cellular assays (Chan et al., 2017). 
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Figure Captions 
 
Figure 1. Inhibitors used in the present work. Inhibitors 1 and 2 have been published previously 
under the names cn-716 and cn-729 (Lei et al., 2016; Nitsche et al., 2017) and inhibitor 3 has 
been reported by Lim et al. (2016). 
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Figure 2.  Superimposition of [15N,1H]-HSQC spectra of 0.12 mM solutions of uniformly 15N-
labelled Zika virus NS2B-NS3 protease in NMR buffer (20 mM MES, pH 6.5) with (blue 
spectrum) and without inhibitor 1 (red spectrum). The inhibitor was added in 1.5-fold excess. 
Assignments are shown for resolved cross-peaks that were changed by the presence of inhibitor. 
Cross-peaks of NS2B are marked with a star. Magenta and black labels highlight cross-peaks of 
NS2Bc residues without and with the inhibitor, respectively. N-H cross-peaks of side-chains 
were assigned only by residue type. The group of five cross-peaks near (d1 = 130 ppm; d2 = 10.1 
ppm) are from tryptophan indol rings of which Trp50 is nearest to the substrate binding site. 
 
Figure 3.  Superimposition of [15N,1H]-HSQC spectra of 0.12 mM solutions of the T27C mutant 
of Zika virus NS2B-NS3pro tagged with C2-Tm3+ (blue), C2- Tb3+ (red) or diamagnetic C2-Y3+ 
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(black) in the presence of a 1.5-fold excess of inhibitor 1. Cross-peak assignments of NS3pro and 
NS2B are labelled in black and magenta, respectively.   
 
Figure 4. PCS isosurfaces representing the Dc tensor obtained with the C2-Tm3+ tag attached at 
position 27. The isosurfaces correspond to PCSs of 1 ppm (dark blue), 0.1 ppm (light blue), -1 
ppm (dark red) and -0.1 ppm (light red), and are plotted on the crystal structure of the Zika virus 
NS2B-NS3 protease in complex with inhibitor 1 (PDB ID: 5LC0). The metal position is shown 
as a magenta sphere and the Cα atom of the tag attachment site is indicated by a green sphere. 
The inhibitor 1 is represented by a stick representation. 31 residues, indicated by a dotted line 
and including the Gly4SerGly4 linker, connect the C-terminus of NS2B with the N-terminus of 
NS3pro, but no coordinates are reported for these disordered residues in the crystal structure.  
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Figure 5. Correlation between back-calculated and experimental PCSs of backbone amide 
protons of gZiPro with inhibitor 1. The PCSs of residues used to fit the ∆χ tensor are indicated 
by red triangles. They include all PCSs measured for NS3pro and residues 55*, 56*, 57* and 60* 
of NS2B. PCSs of NS2B residues between residues 68* and 86* (including NS2Bc) are 
indicated by blue circles. These PCSs are well explained by the Dc tensor, although they were 
not used in the Dc-tensor fit.  
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Figure 6.  Crystal structure 5LC0 of the Zika virus NS2B-NS3 protease with spheres 
highlighting the backbone amides for which chemical shift changes upon binding of inhibitor 
could be assessed. The magnitude of chemical shift change is depicted on a colour scale from red 
(>0.1 ppm) to blue (>0.01 ppm). Grey spheres indicate amides without significant change in 
chemical shift (<0.01 ppm).  (A) Results for inhibitor 3. The amide protons of His51 and Tyr130, 
for which the [15N,1H]-cross-peaks disappear rather than shift upon titration with the inhibitor, 
are highlighted by cyan spheres. (B) Results for inhibitor 1. 
 
